BLOISE, RAFFAELLA

BLOISE, RAFFAELLA  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 1-gen-2000 Schwartz, Peter; Priori, SILVIA GIULIANA; Dumaine, R; Napolitano, C; Antzelevitch, C; Stramba Badiale, M; Richard, Ta; Berti, Mr; Bloise, Raffaella
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 1-gen-2020 Mazzanti, A.; Briani, M.; Kukavica, D.; Bulian, F.; Marelli, S.; Trancuccio, A.; Monteforte, N.; Manciulli, T.; Morini, M.; Carlucci, A.; Viggiani, G.; Cannata, F.; Negri, S.; Bloise, R.; Memmi, M.; Gambelli, P.; Carbone, A.; Molteni, M.; Bianchini, R.; Salgarello, R.; Sozzi, S.; De Cata, P.; Fanfulla, F.; Ceriana, P.; Locatelli, C.; Napolitano, C.; Chiovato, L.; Tomasi, L.; Stefanini, G. G.; Condorelli, G.; Priori, S. G.
Basi genetiche della morte cardiaca improvvisa 1-gen-2000 Priori, SILVIA GIULIANA; Bloise, Raffaella
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 1-gen-2013 Di Pasquale, E; Lodola, F; Miragoli, M; Denegri, M; Avelino Cruz, Je; Buonocore, M; Nakahama, H; Portararo, P; Bloise, Raffaella; Napolitano, C; Condorelli, G; Priori, SILVIA GIULIANA
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. 1-gen-2004 De Rosa, G; Delogu, Ab; Piastra, M; Chiaretti, A; Bloise, Raffaella; Priori, SILVIA GIULIANA
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 1-gen-2002 Priori, SILVIA GIULIANA; Napolitano, C; Memmi, M; Colombi, Barbara; Drago, F; Gasparini, M; De Simone, L; Coltorti, F; Bloise, Raffaella; Keegan, R; Cruz Filho, Fes; Vignati, G; Benatar, A; Delogu, A.
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 1-gen-2016 Curcio, Antonio; Mazzanti, Andrea; Bloise, Raffaella; Monteforte, Nicola; Indolfi, Ciro; Priori, SILVIA GIULIANA; Napolitano, Carlo
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 1-gen-2004 Mok, Ns; Priori, SILVIA GIULIANA; Napolitano, C; Chan, Kk; Bloise, Raffaella; Chan, Hw; Fung, Wh; Chan, Ys; Chan, Wk; Lam, C; Chan, Ny; Tsang, H. H.
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 1-gen-2014 Napolitano, C; Bloise, Raffaella; Memmi, M; Priori, SILVIA GIULIANA
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 1-gen-2019 Mazzanti, A.; Tenuta, E.; Marino, M.; Pagan, E.; Morini, M.; Memmi, M.; Colombi, B.; Tibollo, V.; Frassoni, S.; Curcio, A.; Raimondo, C.; Maltret, A.; Monteforte, N.; Bloise, R.; Napolitano, C.; Bellazzi, R.; Bagnardi, V.; Priori, S. G.
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 1-gen-2007 Ruan, Y; Liu, N; Bloise, Raffaella; Napolitano, C; Priori, SILVIA GIULIANA
Gene-specific therapy for inherited arrhythmogenic diseases 1-gen-2006 Napolitano, C; Bloise, Raffaella; Priori, SILVIA GIULIANA
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 1-gen-2016 Mazzanti, Andrea; Maragna, Riccardo; Faragli, Alessandro; Monteforte, Nicola; Bloise, Raffaella; Memmi, Mirella; Novelli, Valeria; Baiardi, Paola; Bagnardi, Vincenzo; Etheridge, Susan P.; Napolitano, Carlo; Priori, SILVIA GIULIANA
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 1-gen-2017 Mazzanti, A; Maragna, R; Vacanti, Gaetano; Kostopoulou, A; Marino, M; Monteforte, N; Bloise, R; Underwood, K; Tibollo, V; Pagan, E; Napolitano, C; Bellazzi, R; Bagnardi, V; Priori, Sg.
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 1-gen-2021 Curcio, A.; Malovini, A.; Mazzanti, A.; Memmi, M.; Gambelli, P.; La Rosa, F.; Bloise, R.; Indolfi, C.; Bellazzi, R.; Napolitano, C.
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 1-gen-2004 Gasparini, M; Lunati, M; Galimberti, P; Bloise, Raffaella; Fiore, I; Priori, SILVIA GIULIANA
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 1-gen-2018 Mazzanti, A; Maragna, R; Vacanti, G; Monteforte, N; Bloise, R; Marino, M; Braghieri, L; Gambelli, Patrick; Memmi, Mirella; Pagan, E; Morini, M; Malovini, A; Ortiz, Michael; Sacilotto, L; Bellazzi, R; Monserrat, L; Napolitano, C; Bagnardi, V; Priori, Sg.
L-TYPE CALCIUM CHANNEL DISEASE 1-gen-2008 Ruan, Y; Bloise, Raffaella; Napolitano, C; Priori, SILVIA GIULIANA
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 1-gen-1999 Napolitano, C; Bloise, Raffaella; Ronchetti, E; Memmi, M; Schwartz, Peter; Priori, SILVIA GIULIANA
Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia 1-gen-2001 Priori, SILVIA GIULIANA; Napolitano, C; Tiso, N; Memmi, M; Vignati, G; Bloise, Raffaella; Sorrentino, V; Danieli, Ga